MAPT and Alzheimer disease: Although the presence of Ng in the CSF confirmed its diagnostic power, as the increased concentration correlated positively with Tau levels, no differences were found at the plasma level between controls and AD patients, suggesting the unreliability of plasmatic Ng for diagnosing AD [98,99].